Viruses are a significant cause of human cancer and are an even more common cause of cancer in immune deficient humans such as organ transplant recipients or HIV infected people. Analyses of the way viruses alter cell growth has also frequently led to the delineation of novel pathways of cell growth, cell survival and oncogenicity. This Viral Oncology Training Program will provide support for 2 graduate students for G2 or G3 years and for 5 post-doctoral trainees each year for the laboratories of 16 Viral Oncology Program faculty members at Harvard University and its closely affiliated institutions. The research objectives of these laboratories include: (1) Molecular pathogenesis of Human Papillomavirus induced malignancies including cervical, anogenital and oral cancer. (2) Molecular pathogenesis human and primate gamma herpes virus induced malignancies including lymphoproliferative disease and nasopharyngeal carcinoma. (3) Molecular mechanisms by which small DMA tumor viruses including Papovaviruses and ? Adenoviruses alter cell growth and survival. (4) Molecular mechanisms by which RNA tumor viruses infect and alter cell signal transduction, transcription, cell cycle regulation, and cell survival, and (5) Translational research in areas 1 and 2 including therapeutic target identification, target validation, small molecule screens, and experimental models, as well as programmatic objectives that emerge through interactions with disease and population based investigators. Graduate students engage in viral oncology laboratory research training while pursue 3 semesters of course work in molecular biology, genetics, cell biology, virology and immunology. The course work is based in reading of research papers and proposal writing. By January of year 2, students are in full time mentored thesis research. Post-doctoral fellows engage full time in mentored research training. Pre- and post-doctoral students also participate in seminars, journal clubs, and research conferences including conferences of the Virology Program and of the DF/HCC Viral Oncology Program. Trainees are jointly mentored by research trainer and by other program faculty. On completion of their thesis research pre-doctoral students are prepared for postdoctoral research in viral oncology and related disciplines. Postdoctoral trainees are prepared for independent research in viral oncology and related disciplines. This application has been revised to comply with suggestions made in the previous review. ? ?

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
5T32CA009031-30
Application #
7126000
Study Section
Subcommittee G - Education (NCI)
Program Officer
Damico, Mark W
Project Start
1986-07-01
Project End
2010-05-31
Budget Start
2006-06-01
Budget End
2007-05-31
Support Year
30
Fiscal Year
2006
Total Cost
$260,417
Indirect Cost
Name
Harvard University
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
047006379
City
Boston
State
MA
Country
United States
Zip Code
02115
de Wispelaere, Melissanne; LaCroix, Amy J; Yang, Priscilla L (2013) The small molecules AZD0530 and dasatinib inhibit dengue virus RNA replication via Fyn kinase. J Virol 87:7367-81
Spangle, Jennifer M; Munger, Karl (2013) The HPV16 E6 oncoprotein causes prolonged receptor protein tyrosine kinase signaling and enhances internalization of phosphorylated receptor species. PLoS Pathog 9:e1003237
Spangle, Jennifer M; Ghosh-Choudhury, Nayana; Munger, Karl (2012) Activation of cap-dependent translation by mucosal human papillomavirus E6 proteins is dependent on the integrity of the LXXLL binding motif. J Virol 86:7466-72
Vetter, Michael L; Rodgers, Mary A; Patricelli, Matthew P et al. (2012) Chemoproteomic profiling identifies changes in DNA-PK as markers of early dengue virus infection. ACS Chem Biol 7:2019-26
Gewurz, Benjamin E; Towfic, Fadi; Mar, Jessica C et al. (2012) Genome-wide siRNA screen for mediators of NF-?B activation. Proc Natl Acad Sci U S A 109:2467-72
Gheuens, Sarah; Bord, Evelyn; Kesari, Santosh et al. (2011) Role of CD4+ and CD8+ T-cell responses against JC virus in the outcome of patients with progressive multifocal leukoencephalopathy (PML) and PML with immune reconstitution inflammatory syndrome. J Virol 85:7256-63
Gewurz, Benjamin E; Mar, Jessica C; Padi, Megha et al. (2011) Canonical NF-kappaB activation is essential for Epstein-Barr virus latent membrane protein 1 TES2/CTAR2 gene regulation. J Virol 85:6764-73
Gheuens, Sarah; Fellay, Jacques; Goldstein, David B et al. (2010) Role of human leukocyte antigen class I alleles in progressive multifocal leukoencephalopathy. J Neurovirol 16:41-7
Gheuens, Sarah; Pierone, Gerald; Peeters, Patrick et al. (2010) Progressive multifocal leukoencephalopathy in individuals with minimal or occult immunosuppression. J Neurol Neurosurg Psychiatry 81:247-54
Spangle, Jennifer M; Münger, Karl (2010) The human papillomavirus type 16 E6 oncoprotein activates mTORC1 signaling and increases protein synthesis. J Virol 84:9398-407

Showing the most recent 10 out of 53 publications